Summary Highlights:
- Procter & Gamble (PG, Financial) sees a 1% boost in organic sales for Q3 2025, fueled by new product launches like Crest 3D White and Tide OxyBoost.
- The company has returned $3.8 billion to shareholders and updated its fiscal 2025 EPS guidance to $6.72-$6.82.
- Analyst consensus indicates an "Outperform" status for PG with a projected upside of over 12%.
Procter & Gamble's Robust Q3 2025 Performance
Procter & Gamble (NYSE: PG) reported a 1% increase in organic sales for the third quarter of 2025. Notable contributions to this growth came from innovative product launches such as Crest 3D White and Tide OxyBoost. The company demonstrated its commitment to returning value to shareholders by distributing $3.8 billion. Furthermore, P&G has adjusted its fiscal 2025 EPS guidance, forecasting between $6.72 and $6.82. However, the company continues to face challenges, notably $200 million in commodity costs.
Wall Street Analysts' Projections
The outlook from Wall Street analysts remains optimistic. With one-year price targets from 25 analysts, the average target price for Procter & Gamble Co (PG, Financial) stands at $178.81. The range of estimates extends from a high of $200.00 to a low of $144.22. Currently trading at $158.86, this average indicates a potential upside of 12.56%. For more detailed analyses, refer to the Procter & Gamble Co (PG) Forecast page.
The consensus recommendation from 29 brokerage firms places Procter & Gamble Co's (PG, Financial) average recommendation at 2.2, corresponding to an "Outperform" status. This ranking is within a 1 to 5 scale, where 1 denotes a Strong Buy, and 5 indicates a Sell.
Understanding the GF Value
According to GuruFocus estimates, the estimated GF Value for Procter & Gamble Co (PG, Financial) in one year is $166.75. This suggests a potential upside of 4.97% from the current price of $158.86. The GF Value represents GuruFocus' estimation of the stock's fair trading value, calculated via historical trading multiples, past business growth, and future performance projections. More comprehensive information is available on the Procter & Gamble Co (PG) Summary page.
